Enhance Cryo-EM Enabled Gene to Structure Workflow
Partnership will accelerate medicinal chemistry analysis and membrane protein research.
San Diego, California, June 4th, 2024 -- NanoImaging Services (“NIS”), the leading provider of cryo-electron microscopy (“cryo-EM”) services to the pharmaceutical and biotechnology communities, and Cube Biotech, a pioneer in membrane protein production and purification technologies, have announced a partnership agreement to develop a streamlined, cryo-EM enabled gene-to-structure workflow, to ultimately accelerate medicinal chemistry analysis and revolutionize the field of membrane protein research.
Cube is picking up the pace: NanoImaging is only the first of a series of strategic partnerships. Stay tuned!
This strategic partnership will bring together NanoImaging Services’ industry-leading expertise and innovation in high-resolution structural enablement by cryo-EM and Cube Biotech’s innovative polymer technologies and world-leading protein production platform to enable the management of projects from construct design through to final maps and subsequent protein supply and analyses for medicinal chemistry cycles. This seamlessly integrated workflow will facilitate target and structure validation more efficiently and cost-effectively for companies with challenging targets, streamlining drug discovery pipelines and ultimately reducing the time to clinic.
Giovanna Scapin, Ph.D., Chief Scientific Officer at NanoImaging Services said, “One of the strongest predictors of success in structural enablement of drug discovery targets is the purity, homogeneity, and in-depth biochemical and biophysical characterization of the reagents involved. This agreement brings together our industry-leading expertise and innovation in high-resolution structural enablement by cryo-EM with a worldwide leader in protein production and characterization. Together, we aim to successfully target the most complex and challenging projects in drug discovery for our shared clients in a time-effective manner.”
Jan Kubicek, Ph.D., Chief Scientific Officer at Cube Biotech said, “Cube Biotech’s advanced polymer technology solubilizes membrane proteins in their native state, avoiding the use of traditional detergents that can wash away lipids and potentially lead to misfolding and incorrect structures. This innovative method ensures that membrane proteins retain their natural configuration, providing a more accurate representation of their behavior in biological systems.”
John Rigg, Chief Executive Officer at Nanoimaging Services, said ‘’By combining forces and aligning these already successful companies and proven workflows, target enablement and medicinal chemistry timelines can be shortened significantly. This, along with the increased success rates, can reduce the overall investment costs and create a more efficient workflow.”
Barbara Maertens, Ph.D., Chief Operating Officer of Cube Biotech, added, “This collaboration combines our proprietary polymer technologies with NanoImaging Services’ cryo-EM expertise, creating a powerful synergy that will enhance the accuracy and efficiency of membrane protein research. We look forward to the groundbreaking discoveries that will result from this partnership.”
About NanoImaging Services, Inc.
NanoImaging Services, Inc. was launched in 2007 to provide cryo-electron microscopy imaging services to the pharmaceutical, biotechnology, and nanotechnology communities. NIS is a client-focused organization with a reputation for expertise, reliability, and collaboration. NIS is committed to expanding its service capacity through microscope acquisition, workflow automation, recruitment and training of top talent, and development of new service offerings. Their state-of-the-art facilities include a range of electron microscopes, sample preparation equipment, and computational infrastructure to support structural biology and nanoparticle characterization workflows. NIS is the largest and most comprehensive provider of TEM and cryo-EM services to the industrial life science market. For more information, visit: www.nanoimagingservices.com.
About Cube Biotech
At Cube Biotech, membrane protein scientists provide services and products, focusing on protein preparation, biophysical target characterization, and structure determination or assay development. They manufacture a wide range of products for chromatography and protein stabilization in-house. Their distinguishing feature is an extensive synthetic copolymer portfolio, which, unlike detergents, offers a broad and native picture of your target and its function, including amino acid complexes and lipid structures. For more information, visit: https://cube-biotech.com.
San Diego, California, June 4th, 2024 -- NanoImaging Services (“NIS”), the leading provider of cryo-electron microscopy (“cryo-EM”) services to the pharmaceutical and biotechnology communities, and Cube Biotech, a pioneer in membrane protein production and purification technologies, have announced a partnership agreement to develop a streamlined, cryo-EM enabled gene-to-structure workflow, to ultimately accelerate medicinal chemistry analysis and revolutionize the field of membrane protein research.
Cube is picking up the pace: NanoImaging is only the first of a series of strategic partnerships. Stay tuned!
This strategic partnership will bring together NanoImaging Services’ industry-leading expertise and innovation in high-resolution structural enablement by cryo-EM and Cube Biotech’s innovative polymer technologies and world-leading protein production platform to enable the management of projects from construct design through to final maps and subsequent protein supply and analyses for medicinal chemistry cycles. This seamlessly integrated workflow will facilitate target and structure validation more efficiently and cost-effectively for companies with challenging targets, streamlining drug discovery pipelines and ultimately reducing the time to clinic.
Giovanna Scapin, Ph.D., Chief Scientific Officer at NanoImaging Services said, “One of the strongest predictors of success in structural enablement of drug discovery targets is the purity, homogeneity, and in-depth biochemical and biophysical characterization of the reagents involved. This agreement brings together our industry-leading expertise and innovation in high-resolution structural enablement by cryo-EM with a worldwide leader in protein production and characterization. Together, we aim to successfully target the most complex and challenging projects in drug discovery for our shared clients in a time-effective manner.”
Jan Kubicek, Ph.D., Chief Scientific Officer at Cube Biotech said, “Cube Biotech’s advanced polymer technology solubilizes membrane proteins in their native state, avoiding the use of traditional detergents that can wash away lipids and potentially lead to misfolding and incorrect structures. This innovative method ensures that membrane proteins retain their natural configuration, providing a more accurate representation of their behavior in biological systems.”
John Rigg, Chief Executive Officer at Nanoimaging Services, said ‘’By combining forces and aligning these already successful companies and proven workflows, target enablement and medicinal chemistry timelines can be shortened significantly. This, along with the increased success rates, can reduce the overall investment costs and create a more efficient workflow.”
Barbara Maertens, Ph.D., Chief Operating Officer of Cube Biotech, added, “This collaboration combines our proprietary polymer technologies with NanoImaging Services’ cryo-EM expertise, creating a powerful synergy that will enhance the accuracy and efficiency of membrane protein research. We look forward to the groundbreaking discoveries that will result from this partnership.”
About NanoImaging Services, Inc.
NanoImaging Services, Inc. was launched in 2007 to provide cryo-electron microscopy imaging services to the pharmaceutical, biotechnology, and nanotechnology communities. NIS is a client-focused organization with a reputation for expertise, reliability, and collaboration. NIS is committed to expanding its service capacity through microscope acquisition, workflow automation, recruitment and training of top talent, and development of new service offerings. Their state-of-the-art facilities include a range of electron microscopes, sample preparation equipment, and computational infrastructure to support structural biology and nanoparticle characterization workflows. NIS is the largest and most comprehensive provider of TEM and cryo-EM services to the industrial life science market. For more information, visit: www.nanoimagingservices.com.
About Cube Biotech
At Cube Biotech, membrane protein scientists provide services and products, focusing on protein preparation, biophysical target characterization, and structure determination or assay development. They manufacture a wide range of products for chromatography and protein stabilization in-house. Their distinguishing feature is an extensive synthetic copolymer portfolio, which, unlike detergents, offers a broad and native picture of your target and its function, including amino acid complexes and lipid structures. For more information, visit: https://cube-biotech.com.
- IPHASE食蟹猴原代細(xì)胞的技術(shù)優(yōu)勢(shì)和藥物代謝研究中的應(yīng)用
- 原代肝細(xì)胞-代謝功能障礙相關(guān)脂肪性肝炎（MASH）研究的核心模型
- IPHASE 巴馬小型豬皮膚S9助力藥物代謝研究
- 選用離體人皮膚作為體外透皮試驗(yàn)的皮膚模型的優(yōu)勢(shì)
- 體外染色體畸變?cè)囼?yàn)原理、試驗(yàn)設(shè)計(jì)及常見問題解答
- IPHASE 新西蘭兔肺微粒體助力藥物代謝研究
- 肝臟免疫與疾病研究的核心工具-肝Kupffer細(xì)胞的特點(diǎn)及作用
- 大腸桿菌生產(chǎn)中發(fā)酵車間噬菌體污染的原因及應(yīng)對(duì)措施
- IPHASE/匯智和源亮相BIONNOVA生物醫(yī)藥創(chuàng)新者論壇
- IPHASE——?jiǎng)?chuàng)新藥體外評(píng)價(jià)生物試劑國(guó)產(chǎn)替代先行者
- IPHASE精彩亮相BIOCHINA2025易貿(mào)生物產(chǎn)業(yè)展覽
- IPHASE邀您相聚第64屆美國(guó)毒理學(xué)會(huì)年會(huì)SOT 2025
- IPHASE亮相第十四屆藥理學(xué)會(huì)藥物和化學(xué)異物代謝會(huì)議
- IPHASE亮相第十四屆藥物和化學(xué)異物代謝學(xué)術(shù)會(huì)議
- IPHASE助力區(qū)域創(chuàng)新發(fā)展活動(dòng)暨產(chǎn)學(xué)研聯(lián)動(dòng)創(chuàng)新交流會(huì)
- IPHASE課堂第三期：轉(zhuǎn)運(yùn)體研究原理及設(shè)計(jì)
Copyright(C) 1998-2025 生物器材網(wǎng) 電話：021-64166852;13621656896 E-mail：info@bio-equip.com